Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
BioRestorative Therapies Secures European Patent Allowance for ThermoStem® Metabolic Disease Platform Expanding Intellectual Property Protection Through 2040

BioRestorative receives European patent allowance for ThermoStem® platform, enhancing metabolic treatment potential until 2040.Quiver AI SummaryBioRestorative Therapies, Inc. announced that the European...

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

BRTX : 1.5500 (+6.90%)
BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event

Melville, New York--(Newsfile Corp. - January 17, 2023) - BioRestorative Therapies (NASDAQ: BRTX) ("BioRestorative", "BRTX" or the "Company"), a clinical stage company focused on stem cell-based therapies,...

BRTX : 1.5500 (+6.90%)

Barchart Exclusives

Elon Musk Reveals His One "Core Skill" That Has Propelled Him To Become a $400 Billion Man
Elon Musk, the entrepreneur behind Tesla (TSLA) , SpaceX, and several other transformative companies, offered new insights into what he believes is his primary strength as a startup founder and investor. Speaking candidly about the challenges of building revolutionary products, Musk stated, “If something has to be designed and invented,... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar